DK1761553T3 - MHC molecule-binding tumor-associated peptides - Google Patents

MHC molecule-binding tumor-associated peptides

Info

Publication number
DK1761553T3
DK1761553T3 DK05752606.3T DK05752606T DK1761553T3 DK 1761553 T3 DK1761553 T3 DK 1761553T3 DK 05752606 T DK05752606 T DK 05752606T DK 1761553 T3 DK1761553 T3 DK 1761553T3
Authority
DK
Denmark
Prior art keywords
amino acid
given
peptide
tumor
mhc molecule
Prior art date
Application number
DK05752606.3T
Other languages
English (en)
Inventor
Toni Weinschenk
Claudia Lemmel
Stefan Stevanovic
Hans-Georg Rammensee
Original Assignee
Immatics Biotechnologies Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immatics Biotechnologies Gmbh filed Critical Immatics Biotechnologies Gmbh
Application granted granted Critical
Publication of DK1761553T3 publication Critical patent/DK1761553T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK05752606.3T 2004-05-25 2005-05-24 MHC molecule-binding tumor-associated peptides DK1761553T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004026135A DE102004026135A1 (de) 2004-05-25 2004-05-25 An MHC-Moleküle bindende Tumor-assoziierte Peptide
PCT/EP2005/005619 WO2005116051A2 (de) 2004-05-25 2005-05-24 An mhc-moleküle bindende tumor-assoziierte peptide

Publications (1)

Publication Number Publication Date
DK1761553T3 true DK1761553T3 (da) 2010-02-01

Family

ID=34970615

Family Applications (2)

Application Number Title Priority Date Filing Date
DK05752606.3T DK1761553T3 (da) 2004-05-25 2005-05-24 MHC molecule-binding tumor-associated peptides
DK09000315.3T DK2058323T3 (da) 2004-05-25 2005-05-24 Til MHC-molekyler bindende tumorassocierede peptider

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK09000315.3T DK2058323T3 (da) 2004-05-25 2005-05-24 Til MHC-molekyler bindende tumorassocierede peptider

Country Status (14)

Country Link
US (2) US8008431B2 (da)
EP (2) EP1761553B1 (da)
JP (2) JP4764874B2 (da)
AT (1) ATE446310T1 (da)
AU (1) AU2005247598B2 (da)
CA (2) CA2568254C (da)
CY (2) CY1109672T1 (da)
DE (2) DE102004026135A1 (da)
DK (2) DK1761553T3 (da)
ES (2) ES2333804T3 (da)
PL (2) PL2058323T3 (da)
PT (2) PT1761553E (da)
SI (2) SI1761553T1 (da)
WO (1) WO2005116051A2 (da)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2361930A3 (en) 2007-03-26 2011-10-26 Dako Denmark A/S Multimers of MHC-peptide complexes and uses thereof in Borrelia infectious diseases
US20090004213A1 (en) * 2007-03-26 2009-01-01 Immatics Biotechnologies Gmbh Combination therapy using active immunotherapy
EP3620465A1 (en) 2007-07-03 2020-03-11 Dako Denmark A/S Improved methods for generation, labeling and use of mhc multimers
CN105566450A (zh) * 2007-07-27 2016-05-11 伊玛提克斯生物技术有限公司 免疫疗法的新型免疫抗原表位
AU2012216641B2 (en) * 2007-07-27 2015-02-05 Immatics Biotechnologies Gmbh Novel immunogenic epitopes for immunotherapy
AU2008281015B2 (en) * 2007-07-27 2012-07-26 Immatics Biotechnologies Gmbh Novel immunotherapy against neuronal and brain tumors
WO2009039854A2 (en) 2007-09-27 2009-04-02 Dako Denmark A/S Mhc multimers in tuberculosis diagnostics, vaccine and therapeutics
JPWO2009054470A1 (ja) * 2007-10-25 2011-03-10 東レ株式会社 免疫誘導剤及びその用途
US10968269B1 (en) 2008-02-28 2021-04-06 Agilent Technologies, Inc. MHC multimers in borrelia diagnostics and disease
PT2105501E (pt) * 2008-03-27 2015-12-21 Immatics Biotechnologies Gmbh Nova imunoterapia para tumores neuronais e cerebrais
ATE462442T1 (de) * 2008-04-30 2010-04-15 Immatics Biotechnologies Gmbh Neuartige formulierungen von tumor-assoziierten peptiden, welche an menschliche leukozytenantigene der klasse i oder ii für impfungen binden
PL2119726T5 (pl) 2008-05-14 2018-04-30 Immatics Biotechnologies Gmbh Nowe i silne peptydy MHC klasy II pochodzące z surwiwiny i neurokanu
TW201000115A (en) * 2008-06-11 2010-01-01 Oncotherapy Science Inc IQGAP3 epitope peptides and vaccines containing the same
US10722562B2 (en) 2008-07-23 2020-07-28 Immudex Aps Combinatorial analysis and repair
RU2519089C2 (ru) * 2008-08-05 2014-06-10 Торэй Индастриз, Инк. Способ обнаружения злокачественных опухолей
WO2010016525A1 (ja) * 2008-08-05 2010-02-11 東レ株式会社 免疫誘導剤
CA2733223C (en) 2008-08-05 2018-02-27 Toray Industries, Inc. Pharmaceutical composition comprising anti-caprin-1 antibody for treatment and prevention of cancers
GB0817244D0 (en) 2008-09-20 2008-10-29 Univ Cardiff Use of a protein kinase inhibitor to detect immune cells, such as T cells
RS53782B1 (en) 2008-10-01 2015-06-30 Immatics Biotechnologies Gmbh TUMOR-ASSOCIATED PEPTIDES PREPARED AND ANTI-CHANGE RESPONSE FOR GLIOBLASTOMA (GBM) AND OTHER CANCER TREATMENTS
AU2016204711B2 (en) * 2008-10-01 2018-03-01 Immatics Biotechnologies Gmbh Novel immunotherapy against several tumors including neuronal and brain tumors
US11992518B2 (en) 2008-10-02 2024-05-28 Agilent Technologies, Inc. Molecular vaccines for infectious disease
WO2010037402A1 (en) 2008-10-02 2010-04-08 Dako Denmark A/S Molecular vaccines for infectious disease
EP2418490A4 (en) 2009-04-10 2012-10-10 Lsip Llc TUMOR MARKERS AND USE THEREOF
US8075895B2 (en) * 2009-09-22 2011-12-13 Janssen Pharmaceutica N.V. Identification of antigenic peptides from multiple myeloma cells
US9115200B2 (en) 2010-02-04 2015-08-25 Toray Industries, Inc. Pharmaceutical composition for treating cancer using a monoclonal antibody having immunological reactivity with CAPRIN-1
US8828398B2 (en) 2010-02-04 2014-09-09 Toray Industries, Inc. Pharmaceutical composition for treating and/or preventing cancer
US8911740B2 (en) 2010-02-04 2014-12-16 Toray Industries, Inc. Pharmaceutical composition for treating and/or preventing cancer
HUE040012T2 (hu) 2010-02-04 2019-02-28 Toray Industries Gyógyászati ágens rák kezelésére és/vagy megelõzésére
DK2532366T3 (da) 2010-02-04 2017-01-02 Toray Industries Farmaceutisk sammensætning til behandling og/eller forebyggelse af cancer
ES2543174T3 (es) 2010-02-04 2015-08-17 Toray Industries, Inc. Composición medicinal para el tratamiento y/o la prevención del cáncer
GB201009222D0 (en) * 2010-06-02 2010-07-21 Immatics Biotechnologies Gmbh Improved cancer therapy based on tumour associated antigens derived from cyclin D1
IT1400874B1 (it) * 2010-07-05 2013-07-02 Univ Degli Studi Genova Supporto planare avente una superficie ultrapiatta e dispositivo per la rivelazione di antigeni comprendente detto supporto planare.
MY170949A (en) * 2011-07-11 2019-09-20 Cancer Res Initiatives Foundation A peptide capable of binding with a human leukocyte antigen (hla) molecule, a cancer vaccine derived from said peptide and use of said cancer vaccine
CA2864864C (en) 2012-02-21 2020-05-12 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prevention of cancer
DE102012105193B4 (de) * 2012-06-15 2014-04-03 Eberhard-Karls-Universität Tübingen Universitätsklinikum Stimulation der zellulären Immunantwort gegen das Epstein-Barr-Virus (EBV)
CN104497123B (zh) * 2013-12-23 2017-10-27 南方医科大学 Eps8抗肿瘤ctl表位肽及其应用
CN104497125B (zh) * 2013-12-23 2018-04-27 南方医科大学 Eps8抗肿瘤ctl表位肽及其应用
CN104497124B (zh) * 2013-12-23 2017-10-03 南方医科大学 Eps8抗肿瘤ctl表位肽及其应用
GB201505585D0 (en) * 2015-03-31 2015-05-13 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carinoma (RCC) and other cancers
NL2014935B1 (en) 2015-06-08 2017-02-03 Applied Immune Tech Ltd T cell receptor like antibodies having fine specificity.
GB201511546D0 (en) 2015-07-01 2015-08-12 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
CN108026154B (zh) 2015-07-01 2022-03-08 伊玛提克斯生物技术有限公司 用于卵巢癌和其他癌症免疫治疗的新型肽和肽组合物
MY189596A (en) * 2015-07-15 2022-02-18 Immatics Biotechnologies Gmbh A novel peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
GB201512733D0 (en) * 2015-07-20 2015-08-26 Genagon Therapeutics Ab Therapeutic agents for treating conditions associated with elevated GDF15
CN105859865B (zh) * 2016-05-05 2019-07-05 南方医科大学 一种基于Eps8-EGFR结合域的双重抗肿瘤多肽
CN106645677B (zh) * 2016-11-15 2019-08-09 恒瑞源正（上海）生物科技有限公司 体外检测肿瘤新生抗原特异性t细胞的方法、试剂盒以及肿瘤疫苗
DE102016123893A1 (de) 2016-12-08 2018-06-14 Immatics Biotechnologies Gmbh T-Zellrezeptoren mit verbesserter Bindung
NZ754222A (en) 2016-12-08 2022-02-25 Immatics Biotechnologies Gmbh T cell receptors with improved pairing
GB201700567D0 (en) 2017-01-12 2017-03-01 Genagon Therapeutics Ab Therapeutic agents
CA3137880A1 (en) 2019-05-28 2020-12-03 Rodrigo CEBALLOS LENTINI Systems and methods for processing images to prepare slides for processed images for digital pathology

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840839A (en) * 1996-02-09 1998-11-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein
US5955314A (en) * 1996-11-08 1999-09-21 Incyte Pharmaceuticals, Inc. Regulator of cell signaling
US6255055B1 (en) * 1998-03-09 2001-07-03 Wisconsin Alumni Research Foundation c-myc coding region determinant-binding protein (CRD-BP) and its nucleic acid sequence
US7198920B1 (en) * 1999-01-29 2007-04-03 Corika Corporation HER-2/neu fusion proteins
US6274362B1 (en) * 1999-02-04 2001-08-14 Millennium Pharmaceuticals, Inc. RGS-containing molecules and uses thereof
AU3395900A (en) * 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
EP1300418A1 (en) * 2001-10-04 2003-04-09 Erasmus Universiteit Rotterdam Gene regulation by oligopeptides
JP4097178B2 (ja) * 2000-10-03 2008-06-11 株式会社グリーンペプタイド 腫瘍抗原
US7009040B2 (en) * 2003-01-21 2006-03-07 Arius Research, Inc. Cancerous disease modifying antibodies
AU2002246998A1 (en) * 2001-01-18 2002-07-30 Human Genome Sciences, Inc. 50 human secreted proteins
WO2002078524A2 (en) * 2001-03-28 2002-10-10 Zycos Inc. Translational profiling
DE10225144A1 (de) * 2002-05-29 2003-12-18 Immatics Biotechnologies Gmbh An MHC-Moleküle bindende Tumor-assoziierte Peptide
AU2003258134A1 (en) * 2002-08-09 2004-02-25 Applera Corporation Lung cancer target proteins and use thereof
EP1594447A2 (en) * 2002-10-02 2005-11-16 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
KR20050083719A (ko) * 2002-10-03 2005-08-26 에피뮨 인코포레이티드 최적화된 멀티-에피토프 구성체 및 이의 용도
US7468254B2 (en) * 2003-01-21 2008-12-23 Arius Research Inc. Cytotoxicity mediation of cells evidencing surface expression of MCSP

Also Published As

Publication number Publication date
DK2058323T3 (da) 2012-08-06
DE102004026135A1 (de) 2006-01-05
JP2011224007A (ja) 2011-11-10
ATE446310T1 (de) 2009-11-15
CA2777821C (en) 2015-09-22
JP4764874B2 (ja) 2011-09-07
DE502005008379D1 (de) 2009-12-03
PL1761553T3 (pl) 2010-07-30
WO2005116051A3 (de) 2006-03-02
AU2011202473A1 (en) 2011-06-16
CY1109672T1 (el) 2014-08-13
EP2058323B1 (de) 2012-05-16
US20100029573A1 (en) 2010-02-04
WO2005116051A2 (de) 2005-12-08
EP1761553B1 (de) 2009-10-21
EP2058323A1 (de) 2009-05-13
ES2333804T3 (es) 2010-03-01
CA2568254A1 (en) 2005-12-08
PT1761553E (pt) 2009-12-22
CY1112984T1 (el) 2016-04-13
US8242239B2 (en) 2012-08-14
SI2058323T1 (sl) 2012-08-31
PL2058323T3 (pl) 2012-09-28
SI1761553T1 (sl) 2010-01-29
CA2568254C (en) 2016-04-19
US20100021441A1 (en) 2010-01-28
AU2005247598B2 (en) 2011-06-02
EP1761553A2 (de) 2007-03-14
PT2058323E (pt) 2012-07-10
US8008431B2 (en) 2011-08-30
JP2008500033A (ja) 2008-01-10
CA2777821A1 (en) 2005-12-08
JP5182770B2 (ja) 2013-04-17
AU2005247598A1 (en) 2005-12-08
ES2385532T3 (es) 2012-07-26

Similar Documents

Publication Publication Date Title
DK1761553T3 (da) MHC molecule-binding tumor-associated peptides
WO2005030797A3 (en) Melanocortin receptor agonists
DE502005006284D1 (de) Keratin-bindende polypeptide
IL195338A (en) An antibody comprising an FC variant containing amino acid replaces d or e at position 239, a medicament containing it and its use
WO2009004054A3 (en) A cxc chemokine receptor 4 (cxcr4) antagonistic polypeptide
ATE499382T1 (de) Generierung künstlicher bindungsproteine auf der grundlage von ubiquitin-proteinen
NO20063026L (no) Antistoffer
WO2004045553A3 (en) Ca125 gene and its use for diagnostic and therapeutic interventions
NO20071592L (no) GLP-1 og exendinrelatert oppfinnelse
WO2004099231A3 (en) Glycopegylation methods and proteins/peptides produced by the methods
MY149128A (en) A method for the mass production of immunoglobulin fc region deleted initial methionine residues
MXPA04008077A (es) Anticuerpos ant-a° y su uso.
PE20090225A1 (es) Proteinas de fusion que degradan el peptido beta amiloide
RS92704A (en) Immunoglobulin-domain containing cell surface recognition molecules
WO2001047956A3 (en) Method for obtaining proteins having improved functional characteristics
WO2005059131A3 (en) Protein binding miniature proteins and uses thereof
DK1066328T3 (da) Kimært protein, der indeholder en intramolekylær chaperon-lignende sekvens, og dets anvendelse til insulinproduktion
WO2007058267A8 (ja) 新規タンパク質及びそれをコードする遺伝子
EP1842911A4 (en) HLA BINDING PEPTIDES, FOR THOSE CODING DNA FRAGMENTS AND RECOMBINANT VECTORS
DK1551977T3 (da) Selektiv, lokal aktivering af medlemmer af TNF-ligand-familien af systemisk inaktive ikke-antistof-TNF-ligand-fusionsproteiner
WO2005072766A3 (en) Peptides that bind to hsp90 proteins
DE602004028266D1 (de) Angiogene peptide und ihre verwendungen
EP1757687A4 (en) HLA BINDING PEPTIDE, PRE-STEP, DNA DOMAGING AND RECOMBINANT VECTOR
WO2007066018A3 (fr) Peptides qui peuvent se lier a la proteine nef et leurs applications pharmaceutiques
ATE449107T1 (de) Aus fisch gewonnene peptide und nukleinsäuren der cathelicidin familie und deren verwendung